Cargando…
Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
Adaptive designs are a class of methods for improving efficiency and patient benefit of clinical trials. Although their use has increased in recent years, research suggests they are not used in many situations where they have potential to bring benefit. One barrier to their more widespread use is a...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364623/ https://www.ncbi.nlm.nih.gov/pubmed/35945610 http://dx.doi.org/10.1186/s12916-022-02445-7 |
_version_ | 1784765182230134784 |
---|---|
author | Wason, James M. S. Dimairo, Munyaradzi Biggs, Katie Bowden, Sarah Brown, Julia Flight, Laura Hall, Jamie Jaki, Thomas Lowe, Rachel Pallmann, Philip Pilling, Mark A. Snowdon, Claire Sydes, Matthew R. Villar, Sofía S. Weir, Christopher J. Wilson, Nina Yap, Christina Hancock, Helen Maier, Rebecca |
author_facet | Wason, James M. S. Dimairo, Munyaradzi Biggs, Katie Bowden, Sarah Brown, Julia Flight, Laura Hall, Jamie Jaki, Thomas Lowe, Rachel Pallmann, Philip Pilling, Mark A. Snowdon, Claire Sydes, Matthew R. Villar, Sofía S. Weir, Christopher J. Wilson, Nina Yap, Christina Hancock, Helen Maier, Rebecca |
author_sort | Wason, James M. S. |
collection | PubMed |
description | Adaptive designs are a class of methods for improving efficiency and patient benefit of clinical trials. Although their use has increased in recent years, research suggests they are not used in many situations where they have potential to bring benefit. One barrier to their more widespread use is a lack of understanding about how the choice to use an adaptive design, rather than a traditional design, affects resources (staff and non-staff) required to set-up, conduct and report a trial. The Costing Adaptive Trials project investigated this issue using quantitative and qualitative research amongst UK Clinical Trials Units. Here, we present guidance that is informed by our research, on considering the appropriate resourcing of adaptive trials. We outline a five-step process to estimate the resources required and provide an accompanying costing tool. The process involves understanding the tasks required to undertake a trial, and how the adaptive design affects them. We identify barriers in the publicly funded landscape and provide recommendations to trial funders that would address them. Although our guidance and recommendations are most relevant to UK non-commercial trials, many aspects are relevant more widely. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02445-7. |
format | Online Article Text |
id | pubmed-9364623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93646232022-08-11 Practical guidance for planning resources required to support publicly-funded adaptive clinical trials Wason, James M. S. Dimairo, Munyaradzi Biggs, Katie Bowden, Sarah Brown, Julia Flight, Laura Hall, Jamie Jaki, Thomas Lowe, Rachel Pallmann, Philip Pilling, Mark A. Snowdon, Claire Sydes, Matthew R. Villar, Sofía S. Weir, Christopher J. Wilson, Nina Yap, Christina Hancock, Helen Maier, Rebecca BMC Med Correspondence Adaptive designs are a class of methods for improving efficiency and patient benefit of clinical trials. Although their use has increased in recent years, research suggests they are not used in many situations where they have potential to bring benefit. One barrier to their more widespread use is a lack of understanding about how the choice to use an adaptive design, rather than a traditional design, affects resources (staff and non-staff) required to set-up, conduct and report a trial. The Costing Adaptive Trials project investigated this issue using quantitative and qualitative research amongst UK Clinical Trials Units. Here, we present guidance that is informed by our research, on considering the appropriate resourcing of adaptive trials. We outline a five-step process to estimate the resources required and provide an accompanying costing tool. The process involves understanding the tasks required to undertake a trial, and how the adaptive design affects them. We identify barriers in the publicly funded landscape and provide recommendations to trial funders that would address them. Although our guidance and recommendations are most relevant to UK non-commercial trials, many aspects are relevant more widely. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02445-7. BioMed Central 2022-08-10 /pmc/articles/PMC9364623/ /pubmed/35945610 http://dx.doi.org/10.1186/s12916-022-02445-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correspondence Wason, James M. S. Dimairo, Munyaradzi Biggs, Katie Bowden, Sarah Brown, Julia Flight, Laura Hall, Jamie Jaki, Thomas Lowe, Rachel Pallmann, Philip Pilling, Mark A. Snowdon, Claire Sydes, Matthew R. Villar, Sofía S. Weir, Christopher J. Wilson, Nina Yap, Christina Hancock, Helen Maier, Rebecca Practical guidance for planning resources required to support publicly-funded adaptive clinical trials |
title | Practical guidance for planning resources required to support publicly-funded adaptive clinical trials |
title_full | Practical guidance for planning resources required to support publicly-funded adaptive clinical trials |
title_fullStr | Practical guidance for planning resources required to support publicly-funded adaptive clinical trials |
title_full_unstemmed | Practical guidance for planning resources required to support publicly-funded adaptive clinical trials |
title_short | Practical guidance for planning resources required to support publicly-funded adaptive clinical trials |
title_sort | practical guidance for planning resources required to support publicly-funded adaptive clinical trials |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364623/ https://www.ncbi.nlm.nih.gov/pubmed/35945610 http://dx.doi.org/10.1186/s12916-022-02445-7 |
work_keys_str_mv | AT wasonjamesms practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT dimairomunyaradzi practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT biggskatie practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT bowdensarah practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT brownjulia practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT flightlaura practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT halljamie practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT jakithomas practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT lowerachel practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT pallmannphilip practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT pillingmarka practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT snowdonclaire practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT sydesmatthewr practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT villarsofias practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT weirchristopherj practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT wilsonnina practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT yapchristina practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT hancockhelen practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials AT maierrebecca practicalguidanceforplanningresourcesrequiredtosupportpubliclyfundedadaptiveclinicaltrials |